Posted On: 10/28/2014 3:55:06 PM
Post# of 30035
Exhibit 10.3 from the 10-Q was the license agreement between PGI Drug Discovery LLC and Amarantus BioScience Holdings, Inc. regarding Eltoprazine.
http://www.sec.gov/Archives/edgar/data/142481...ex10-3.htm
The 10-Q filing contains omitted data referenced with the following:
Today's CT ORDER is the SEC's approval of the confidential treatment request for the omitted info.
http://www.sec.gov/Archives/edgar/data/142481...ex10-3.htm
The 10-Q filing contains omitted data referenced with the following:
Quote:
[*] Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portion.
Today's CT ORDER is the SEC's approval of the confidential treatment request for the omitted info.
(0)
(0)Scroll down for more posts ▼
